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M A J O R A R T I C L E
Differential Expression of Chemokines and Their
Receptors in Adult and Neonatal Macrophages
Infected with Human or Avian Influenza Viruses
Jianfang Zhou,1,3 Helen K. W. Law,1,3 Chung Yan Cheung,2,3 Iris H. Y. Ng,2,3 J. S. Malik Peiris,2,3 and Yu Lung Lau1,3
Departments of 1Paediatrics and Adolescent Medicine and 2Microbiology, Hong Kong Jockey Club Clinical Research Centre, Faculty of Medicine,
and 3Research Centre of Infection and Immunology, University of Hong Kong, Pokfulam, Hong Kong SAR, China
In 1997, avian influenza virus H5N1 was transmitted directly from chicken to human and resulted in a severe
disease that had a higher mortality rate in adults than in children. The characteristic mononuclear leukocyte
infiltration in the lung and the high inflammatory response in H5N1 infection prompted us to compare the
chemokine responses between influenza virus–infected adult and neonatal monocyte-derived macrophages
(MDMs). The effects of avian influenza virus A/Hong Kong/483/97 (H5N1) (H5N1/97), its precursor A/Quail/
Hong Kong/G1/97 (H9N2) (H9N2/G1), and human influenza virus A/Hong Kong/54/98 (H1N1) (H1N1/98)
were compared. Significantly higher expression of CCL2, CCL3, CCL5, and CXCL10 was induced by avian
influenza viruses than by human influenza virus. Moreover, the increase in CCL3 expression in H5N1/97-
infected adult MDMs was significantly higher than that in neonatal MDMs. Enhanced expression of CCR1
and CCR5 was found in avian virus–infected adult MDMs. The strong induction of chemokines and their
receptors by avian influenza viruses, particularly in adult MDMs, may account for the severity of H5N1 disease.
Chemokines are a large family of small secreted proteins
that can chemoattract leukocyte subpopulations from
the blood to sites of inflammation. They are classified
according to the cysteine motif into 4 subgroups—
namely, CC, CXC, C, and CX3C chemokines [1, 2].
The biological effects of chemokines are exerted by their
binding to specific G protein–coupled receptors ex-
pressed on the surface of leukocytes [3]. CC chemokine
receptors are expressed on a wide variety of cells, in-
cluding monocytes/macrophages, lymphocytes, NK cells,
eosinophils, and basophils. CXC receptors predominate
on neutrophils [4, 5].
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After the initial infection of respiratory epithelial cells
by influenza A virus, small numbers of blood-derived
neutrophils and large numbers of blood monocytes/
macrophages extrude into the infected lung. Viral rep-
lication continues in the epithelial cells, and infection
spreads to macrophages [6]. A series of inflammatory
CC chemokines (CCL2, CCL3, CCL5, and CCL11) and
interferon (IFN)–g–responsive chemokines (CXCL1,
CXCL8, CXCL9, and CXCL10) are induced in the in-
fected macrophages [7–10]. These chemokines act as
important mediators for immune cell activation and
recruitment; however, they may be detrimental to the
infected host, resulting in inflammation and organ pa-
thology [1, 2]. CCL3, CCL5, and CXCL10 potentially
contribute to lung pathology by inducing the activation
and migration of cytotoxic T lymphocytes (CTLs) to
the site of influenza infection [11, 12].
Avian influenza virus H5N1 is novel to the human
population and was first identified as transmitting to
humans directly in Hong Kong in 1997 [13]. In contrast
to infection with common human influenza viruses,
infection with this virus is characterized by severe lung
damage with infiltration of macrophages, lymphocytes,
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Forward primer CAT TGT GGC CAA GGA GAT CTG
Reverse primer CTT CGG AGT TTG GGT TTG CTT
Probe (FAM) TGC TGA CCC CAA GCA GAA GTG G (TARMA)
CCL3/MIP1-a 64 gi:4506843
Forward primer CAT CAC TTG CTG CTG ACA CG
Reverse primer TGT GGA ATC TGC CGG GAG
Probe (FAM) CGA CCG CCT GCT GCT TCA GCT ACA (TARMA)
CCL5/RANTES 72 M21121
Forward primer CCC AGC AGT CGT CTT TGT CA
Reverse primer TCC CGA ACC CAT TTC TTC TCT
Probe (FAM) TTG GCA CAC ACT TGG CGG TTC TTT C (TARMA)
CXCL10/IP-10 208 gi:4504700
Forward primer CTG ACT CTA AGT GGC ATT
Reverse primer TGA TGG CCT TCG ATT CTG
Probe (FAM) CAA GGA GTA CCT CTC TCT AGA ACC GTA CGC (TARMA)
CCR1 200 gi:30410906
Forward primer CCC AAT GGG AAT TCA CTC ACC A
Reverse primer CAA ACG GAC AGC TTT GGA TT
Probe (FAM) CCT GCA GCC TTC ACT TTC CTC ACG AAA (TARMA)
CCR5 204 gi:5712805
Forward primer ACT GCA AAA GGC TGA AGA GC
Reverse primer CGA TTG TCA GGA GGA TGA TG
Probe (FAM) ACT GAC ATC TAC CTG CTC AAC CTG GCC A (TARMA)
b-actin 90 gi:1791002
Forward primer GGA TGC AGA AGG AGA TCA CTG
Reverse primer CAA GTA CTC CGTGTG GAT CG
Probe (FAM) CCC TGG CAC CCA GCA CAA TGA (TARMA)
NOTE. IP-10, interferon-inducible protein of 10 kDa; MCP, monocyte chemotactic protein; MIP, macrophage inflammatory protein.
and reactive fibroblasts, as well as by high inflammatory re-
sponses. Reactive hemophagocytosis is one of the notable sys-
temic signs [13–15]. Age-related severity is also found in avian
influenza. Among the 18 humans infected with H5N1 in 1997,
5 of 9 patients aged 112 years died, but only 1 of 9 patients
aged !12 years died [13]. Avian virus H9N2/G1, the precursor
of H5N1 virus, shares some similarities with H5N1 virus, such
as 6 internal genes, a high proinflammatory induction phe-
notype in adult macrophages, and mild clinical features in chil-
dren [15–17].
Our previous studies have demonstrated that neonatal im-
mune cells are functionally immature, compared with their
adult counterparts [18–22]. Hence, we hypothesized that there
are differential immune responses to avian influenza viruses
during the development of the host’s immune system and that
these differences may be related to the clinical severity. In the
present study, we compared the expression of inflammatory
chemokines CCL2, CCL3, CCL5, and CXCL10, as well as that
of the chemokine receptors CCR1 and CCR5, between adult
and neonatal monocyte-derived macrophages (MDMs) infect-
ed with avian influenza virus H5N1/97 or with its precursor,
H9N2/G1.
MATERIALS AND METHODS
Sample collection. Human umbilical-cord blood was ob-
tained from the placentas of healthy, full-term infants, after the
placentas were delivered and separated from the infants, with
the written informed consent of their mothers. Adult blood
was collected from healthy blood donors (from the Hong Kong
Red Cross Blood Transfusion Service). The research protocol
was approved by the Institutional Review Board of the Uni-
versity of Hong Kong/Hospital Authority Hong Kong West
Cluster.
Culture of MDMs. Human MDMs were generated from
mononuclear cells, as described elsewhere [15, 23]. The purity
of monocytes, as determined by flow cytometry (Coulter Epics
Elite; Beckman Coulter) with anti-CD14 monoclonal antibody
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Figure 1. Immunofluorescence staining of viral nucleoprotein (NP) in influenza virus–infected adult and neonatal monocyte-derived macrophages
(MDMs). Day-14 differentiated MDMs were infected by influenza viruses H1N1/98, H9N2/G1, and H5N1/97 at an MOI of 2. At the 12-h point of
infection, cells were fixed and analyzed by immunofluorescent staining specific for influenza A virus matrix protein and NP (green), with Evan’s blue
(red) as a counterstaining. More than 90% of cells were infected.
(PharMingen) was consistently 190%. The monocytes were re-
fed by fresh medium every 2 days and allowed to differentiate
for 14 days in vitro.
Virus preparation, titration, and infection. In view of the
biosafety issues involved in handling highly pathogenic avian
influenza virus A/Hong Kong/483/97 (H5N1/97), we used avian
influenza virus A/Quail/Hong Kong/G1/97 (H9N2/G1) for the
optimization of experiments. The findings were then confirmed
using H5N1/97 virus, and all experiments with H5N1/97 virus
were performed in a Biosafety Level 3 facility.
As described elsewhere [23], viruses were cultured in Madin-
Darby canine kidney (MDCK) cells (ATCC), were purified by
adsorption to and elution from turkey red blood cells [24], and
were stored at 70C until use. The titer of virus stock was
determined by titration in MDCK cells and by daily observation
for cytopathogenic effect and was confirmed by hemagglu-
tination assay [25]. The TCID50 was calculated by the Reed-
Muench formula.
Day-14 differentiated MDMs were infected by influenza vi-
ruses at an MOI of 2. This is taken to be the 0-h point of
infection (POI) for the experiments described below. After virus
adsorption for 1 h at 37C, unadsorbed virus was removed by
washing with PBS. Mock-treated cells were similarly treated in
parallel, except that virus was not added. To determine the
infectivity, cells were fixed and analyzed by immunofluorescent
staining specific for influenza A virus matrix protein (M) and
nucleoprotein (NP) (DAKO Imagen; Dako Diagnostics).
Quantification of mRNA by real-time quantitative reverse-
transcription polymerase chain reaction (RT-PCR). Infected
MDMs (∼ ) cultured in macrophage serum–free medium55 10
(Invitrogen Life Technologies) were harvested at various time
points for total RNA extraction by use of TRIzol Reagent (In-
vitrogen Life Technologies). As described in our previous report
[26], reverse transcription was performed on DNase-treat-
ed total RNA. The cDNA was synthesized from mRNA with
oligo(dT)12–18 primer and Superscript II reverse transcriptase
(Invitrogen Life Technologies). The cDNA samples were diluted
(1:10) and used as template. Specific primers and probes ([26,
27] and table 1) were used in a real-time PCR assay, detect-
ed by use of an ABI PRISM 7700 Sequence Detection System
(Applied Biosystems). The standard curve was generated using
serial dilution of plasmids (from ∼10 to 107 copies) containing
the respective cloned gene targets. Viral M1 gene copies were
quantified on the basis of a SYBR green fluorescence signal
after PCR (forward primer, 5′-CTT CTA ACC GAG GTC GAA
ACG-3′; reverse primer, 5′-GGC ATT TTG GAC AAA GCG
TCT A-3′). Dissociation curve analysis was performed after each
assay, to ensure specific target detection. To standardize results
for variability in RNA and cDNA quantity, we expressed them
as the number of target gene copies per 104 copies of b-actin.
ELISA for supernatants from virus-infected MDMs. Su-
pernatants from 106 mock- or virus-infected MDMs per well
incubated in a volume of 800 mL of RPMI 1640 plus 10% fetal
bovine serum were collected after 6, 12, or 24 h and stored at
70C; thawed; and irradiated at a dosage of 0.2 J/cm2 for 15
min in a UV crosslinker (Spectrolinker) before use. The con-
centrations of CCL3 and CCL5 in culture supernatants were
measured by use of commercially available Duoset ELISA kits
purchased from R&D Systems, in accordance with the man-
ufacturer’s instructions. Each sample was assayed in duplicate.
Samples were read at 450 nm, using a microplate reader (Bio-
Rad), and were analyzed using Microplate Manager software
(version 4.0; Bio-Rad).
Statistical analysis. Data are expressed as . Sta-mean SE
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Figure 2. Kinetics of CCL2, CCL3, CCL5, and CXCL10 mRNA expression in influenza virus–infected adult and neonatal monocyte-derived macrophages
(MDMs). The graphs depict the kinetics of CCL2, CCL3, CCL5, and CXCL10 mRNA expression in mock-infected, H1N1/98-infected, and H9N2/G1-
infected adult MDMs (A–D) and neonatal MDMs (E–H). After influenza virus infection, total RNA was harvested at the 4-h, 8-h, and 12-h points of
infection (POIs). The target genes were quantified by quantitative reverse-transcription polymerase chain reaction and normalized to 104 copies of b-
actin mRNA. The data shown are the from 6 sets of independent experiments. In contrast to H1N1/98, avian influenza virus H9N2/G1mean SE
induced higher levels of CCL2, CCL3, CCL5, and CXCL10. * ; ** .P ! .05 P ! .01
tistical significance was determined by pair or nonpair non-
parametric tests, using Instat software (version 3.05; Graph-
Pad). was considered to be significant.P ! .05
RESULTS
Detection of similar infectivity and viral replication in adult
and neonatal MDMs infected with human and avian influ-
enza viruses. Differences in virulence between avian and hu-
man influenza viruses may be dependent on differences in cell
tropism and in the kinetics of infection and replication. We
first determined the infectivity of human and avian influenza
viruses in adult and neonatal MDMs by immunofluorescence
staining of viral NP. Similar to our previous findings in adult
MDMs [15, 23], 190% of neonatal MDMs were infected at the
12-h POI—that is, within the first round of viral replication
(figure 1).
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Figure 3. Increase in CCL2, CCL3, CCL5, and CXCL10 expression in
H5N1/97-infected adult and neonatal monocyte-derived macrophages
(MDMs), compared with that in H1N1/98-infected MDMs. After influenza
virus infection, total RNA was harvested at the 7-h point of infection.
The target genes were quantified by quantitative reverse-transcription
polymerase chain reaction and normalized to 104 copies of b-actin mRNA.
The fold increase is the normalized no. of target-gene copies in H5N1/
97-infected MDMs divided by the no. in H1N1/98-infected MDMs. Sig-
nificantly higher fold increases in CCL3 expression were detected in H5N1/
97-infected adult MDMs than in neonatal MDMs. The data shown are
the from 6 sets of independent experiments. * .mean SE P ! .05
To quantify viral replication in the infected MDMs, we mea-
sured the copies of viral matrix (M1) gene at the 4-h and 7-h
POIs. An increase in the number of viral M1 gene copies was
observed in adult and neonatal MDMs between the 4-h and
7-h POIs (adult MDMs: H1N1, from to10,949.84 9211.48
copies; H9N2, from48,618.35 27,473.55 8681.06 4066.48
to copies; neonatal MDMs: H1N1, from49,205.68 11,589.67
to copies; H9N2,24,446.35 11,045.67 46,883.99 13,758.16
from to copies; ).8111.12 3529.33 38,131.56 5455.63 np 4
At the 7-h POI, similarly high numbers of M1 gene copies were
found in both adult and neonatal MDMs infected with H1N1/
98, H9N2/G1, or H5N1/97 ( ; ).np 4 P 1 .05
We then measured the titers of viruses released from H1N1/
98- or H9N2/G1-infected adult and neonatal MDMs at the 24-
h POI. The human and avian influenza viruses replicated to
similar extents in adult and neonatal MDMs, and the virus
titers were ∼104 TCID50/mL in the supernatants from MDMs
infected with H1N1/98 or H9N2/G1 ( ; ).np 3 P 1 .05
Up-regulation of CCL2, CCL3, CCL5, and CXCL10 mRNA
expression in adult and neonatal MDMs infected with avian
influenza virus H9N2/G1. After viral infection, the expression
of CCL2, CCL3, CCL5, and CXCL10 mRNA was induced and
progressively increased with time (figure 2). In adult MDMs,
avian influenza virus H9N2/G1 induced higher expression of
CCL3, CCL5, and CXCL10 mRNA at all time points assessed
(4-, 8-, and 12-h POIs) than that induced by human virus
H1N1/98 ( ; ) (figure 2B–2D). However, neonatalnp 6 P ! .01
MDMs showed chemokine responses to both H1N1/98 and
H9N2/G1 that were similar in extent at early time points (4-
h or 8-h POI), and only later did the difference in expression
of these genes between them become significant (figure 2F–
2H).
Only at the 12-h POI was a significant difference in CCL2
expression between H9N2/G1- and H1N1/98-infected MDMs
found ( for adult MDMs [ ; figure 2A];Pp .0079 np 6 Pp
for neonatal MDMs [ ; figure 2E]). Higher expres-.0429 np 6
sion of CCL2 and CCL3 was found in adult MDMs than in
neonatal MDMs infected with H9N2/G1, although the differ-
ence did not reach statistical significance (figure 2A, 2B, 2E,
and 2F).
Significantly higher expression of CCL3 mRNA in adult
MDMs than in neonatal MDMs infected with H5N1/97. We
subsequently repeated the above experiments on H5N1/97-in-
fected MDMs in a Biosafety Level 3 laboratory. To compare
the adult and neonatal MDM chemokine responses to H5N1/
97 with those to human influenza virus H1N1/98, we analyzed
our data as fold increases in chemokine mRNA expression, by
dividing the number of normalized target-gene copies in H5N1/
97-infected MDMs by the number in H1N1/98-infected MDMs.
At the 7-h POI, the expression of CCL2, CCL3, CCL5, and
CXCL10 mRNA was significantly up-regulated by avian influ-
enza virus H5N1/97 (figure 3). Generally, there were greater
fold increases in gene expression in H5N1/97-infected adult
MDMs than in neonatal MDMs (adult MDMs: 18.7515.4,
, , and ; neonatal MDMs:25.67 11.62 17.24 4.84 19.95 9.75
, , , and 16.754.99). Of14.31 8.02 5.66 1.30 12.56 4.41
note, a significantly greater increase in CCL3 expression was
found in H5N1/97-infected adult MDMs than in neonatal
MDMs ( ; ) (figure 3).Pp .0317 np 6
Higher production of CCL3 and CCL5 at an early stage of
infection in adult MDMs than in neonatal MDMs infected
with H9N2/G1. In the supernatants from mock-treated MDMs
after 24 h, CCL3 production was !0.2 ng/mL (0.105 0.028
ng/mL for adult MDMs; ng/mL for neonatal0.088 0.008
MDMs; ), and CCL5 was not detectable. In parallel withnp 4
the gene expression, significantly higher production of CCL3
and CCL5 was found in both H1N1/98-infected and H9N2/
G1-infected MDMs than in mock-infected MDMs (figure 4).
Enhanced production of inflammatory chemokines CCL3 and
CCL5 was detected early, at the 6-h POI, and the concentrations
of these chemokines increased with time. At early time points
(6-h and 12-h POIs), much higher concentrations of CCL3 and
CCL5 were detected in H9N2/G1-infected adult MDMs than
in neonatal MDMs. Compared with H1N1/98-infected MDMs,
there was a 5–10-fold increase in CCL3 and CCL5 production
in H9N2/G1-infected MDMs at the 24-h POI (CCL3 in adult
MDMs, ng/mL vs. ng/mL; CCL3192.73 21.65 46.41 19.40
in neonatal MDMs, ng/mL vs. ng/196.90 34.11 30.59 9.21
mL; CCL5 in adult MDMs, ng/mL vs.8.31 1.17 1.16
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Figure 4. CCL3 and CCL5 produced in H1N1/98- and H9N2/G1-infected monocyte-derived macrophages (MDMs). The supernatants from H1N1/98-
and H9N2/G1-infected MDMs were collected at the 6-h, 12-h, and 24-h points of infection (POIs) and assayed by ELISA, as described in Materials
and Methods. At early time points (6-h and 12-h POIs) after infection with H9N2/G1, much higher concentrations of CCL3 and CCL5 were detected
in adult MDMs than in neonatal MDMs. Compared with those from H1N1/98-infected MDMs, there were 5–10-fold increases in CCL5 and CCL3
concentrations in the culture supernatants from H9N2/G1-infected MDMs at the 24-h POI. The data shown are the from 5 sets ofmean SE
independent experiments. * ; ** .P ! .05 P ! .01
ng/mL; CCL5 in neonatal MDMs, ng/mL vs.0.13 8.67 1.12
ng/mL; ; ).1.31 0.23 P ! .001 np 5
Differential CCR1 and CCR5 expression in adult and neo-
natal MDMs infected with H9N2/G1. It has been reported
that influenza A virus abolishes the functional responsiveness
of monocytes via down-regulation of CCR2 expression but
could induce a slight increase in CCR1 and CCR5 expression
[8]. Virus-induced CCL5 and activation of CCR5 are required
to prevent apoptosis of influenza virus–infected mouse mac-
rophages in vivo and of human macrophages ex vivo [28].
Therefore, we determined whether the expression of chemokine
receptors differed between virus-infected adult and neonatal
MDMs. Chemokine receptors could bind several members of
the same chemokine subgroup with high affinity. Both CCR1
and CCR5 could bind to CCL3 and CCL5 [1, 2, 4, 11]. As
shown in figure 5, little change in CCR1 and CCR5 expression
was found in H1N1/98-infected MDMs. At the 12-h POI, sig-
nificantly higher expression of both CCR1 and CCR5 was de-
tected in H9N2/G1-infected adult MDMs than in H1N1/98-
infected adult MDMs (CCR1, [figure 5A]; CCR5,Pp .0025
[figure 5C]; ). Similar to that in adult MDMs,Pp .0022 np 6
CCR1 expression in H9N2/G1-infected neonatal MDMs dis-
played a gradual increase with time and, at the 12-h POI, was
significantly higher than that in H1N1/98-infected neonatal
MDMs ( ; ) (figure 5B). However, there wasPp .0087 np 6
little change in the expression of CCR5 in H1N1/98- or H9N2/
G1-infected neonatal MDMs, and !20 gene copies/104 copies
of b-actin were detected (figure 5D).
Enhanced CCR1 and CCR5 expression in H5N1/97-infected
adult MDMs. We further compared the expression of CCR1
and CCR5 in H5N1/97-infected MDMs with that in H1N1/98-
infected MDMs at the 7-h POI. The increase in CCR1 and
CCR5 expression in H5N1/97-infected adult MDMs, compared
with that in human virus H1N1/98–infected cells, was ∼6–7-
fold. However, there was no increase seen in H5N1/97-infected
neonatal MDMs, compared with H1N1/98-infected cells. Sig-
nificantly higher fold increases in CCR1 and CCR5 expression
were found in H5N1/97-infected adult MDMs than in neonatal
MDMs (CCR1, ; CCR5, ; ) (figure 6).Pp .0223 Pp .0152 np 6
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Figure 5. CCR1 and CCR5 mRNA expression in influenza virus–infected adult and neonatal monocyte-derived macrophages (MDMs). The graphs depict
the kinetics of CCR1 and CCR5 expression in H1N1/98- and H9N2/G1-infected adult MDMs (A and C ) and neonatal MDMs (B and D ). After influenza
virus infection, total RNA was harvested at the 4-h, 8-h, and 12-h points of infection (POIs). The target genes were quantified by quantitative reverse-
transcription polymerase chain reaction and normalized to 104 copies of b-actin mRNA. Significantly higher expression of both CCR1 and CCR5 were
detected in H9N2/G1-infected adult MDMs than in H1N1/98-infected adult MDMs. Up-regulation of CCR1 expression, but not of CCR5 expression, was
detected in H9N2/G1-infected neonatal MDMs. The data shown are the from 6 sets of independent experiments. * ; ** .mean SE P ! .05 P ! .01
DISCUSSION
In this study, we have demonstrated that human MDMs have
differential responses to human influenza virus H1N1/98 and
avian viruses H9N2/G1 and H5N1/97, in spite of their similar
infectivity and viral replication. Moreover, stronger chemokine
and chemokine-receptor responses to avian influenza viruses
were detected in adult MDMs than in neonatal MDMs.
Consistent with the findings in other studies of chemokine
responses to human influenza viruses [7, 8, 10], inflammatory
CC chemokines and IFN-responsive chemokines were induced
by avian influenza viruses in our experiments. Furthermore, sig-
nificantly higher expression of CCL2, CCL3, CCL5, and CXCL10
was found in response to avian influenza viruses, compared
with human influenza viruses (figures 2 and 4). Expression of
these chemokines is also up-regulated in other viral infections,
such as lymphocyte choriomeningitis virus, West Nile virus,
respiratory syncytial virus, and hepatitis C virus infections [29–
32]. The chemokine-dependent trafficking of monocytes/mac-
rophages, dendritic cells, NK cells, and lymphocytes between
the site of infection, the circulation, and the draining lymph
nodes provides protective immunity against viral infections.
Paradoxically, the same chemokines could exacerbate virus-
induced inflammation and pathology via exaggerated cell-me-
diated responses [1, 2, 31, 32]. Therefore, the rapid and strong
chemokine response detected in both adult and neonatal MDMs
infected with avian influenza viruses may partially explain the
greater clinical severity observed.
The kinetics of chemokine production in avian influenza
virus H9N2/G1–infected MDMs suggested that the CCL3 and
CCL5 responses were stronger in adult MDMs than in neonatal
MDMs at an early stage (figure 4). Strikingly, the fold increase
in CCL3 expression in H5N1/97-infected adult MDMs was
significantly higher than that in neonatal MDMs (figure 3). The
detrimental effects of CCL3 have been widely studied in viral
infections. Higher CCL3, interleukin (IL)–6, IL-8, and IL-1
levels have been found in plasma from patients with fatal H5N1
infection than in plasma from survivors [14]. Elevated CCL3
and IFN-g levels have been detected in inflammatory tissues
from patients with infection-induced hemophagocytic syndrome
[33]. Additionally, levels of CCL3, but not of other CC che-
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Figure 6. Enhanced CCR1 and CCR5 expression in H5N1/97-infected
adult monocyte-derived macrophages (MDMs). After influenza virus in-
fection, total RNA was harvested at the 7-h point of infection. The target
genes were quantified by quantitative reverse-transcription polymerase
chain reaction and normalized to 104 copies of b-actin mRNA. The fold
increase is the normalized no. of target-gene copies in H5N1/97-infected
MDMs divided by the no. in H1N1/98-infected MDMs. Higher fold in-
creases in CCR1 and CCR5 expression were detected in H5N1/97-infected
adult MDMs than in neonatal MDMs. The data shown are the
from 6 sets of independent experiments. * .mean SE P ! .05
mokines (CCL2 and CCL5), have been found to be higher in
nasopharyngeal secretions from infants with more-severe hyp-
oxic bronchiolitis due to influenza virus [34]. It has been found
that less mononuclear cell infiltration and pulmonary edema
occurs in gene-deficient CCL3/ mice than in wild-type mice
during respiratory virus infection [35, 36]. The higher CCL3
response in adult MDMs may be one of the important factors
responsible for the age-related severity of avian influenza virus
infection in 1997.
Both CCR1 and CCR5 are able to bind CCL3. The process
by which human monocytes mature into tissue macrophages
is accompanied by a loss in CCR2 expression, an increase in
expression of CCR1 and CCR5, and an enhanced functional
response to CCL3 [37, 38]. During influenza virus infection,
CCL3 may primarily function through CCR1 or CCR4, and its
interaction with CCR5 is limited [39]. Moreover, activation of
CCR1 is an early event in the systemic inflammatory response
and occurs in various cell types [40, 41]. The trafficking of
myeloid cells and neutrophils is disordered in CCR1/ mice
[41]. Improved survival was detected in gene-deleted CCR1/
mice infected with pneumonia virus, compared with that in
wild-type mice [42]. We detected the up-regulation of both
CCR1 and CCR5 expression in avian virus H9N2/G1–infected
adult MDMs; however, only CCR1 expression was up-regulated
in H9N2/G1-infected neonatal MDMs (figure 5). These results
suggested that the activation of CCR1 may be the major re-
sponse in macrophages to avian influenza virus. In contrast to
H5N1/97-infected adult MDMs, which had a several-fold in-
crease in CCR1 and CCR5 production, H5N1/97-infected neo-
natal MDMs had a minimal fold increase of CCR1 and CCR5
production at the 7-h POI (figure 6). The difference may be
explained by delayed chemokine-receptor activation of neonatal
MDMs in response to H5N1/97 virus, compared with that of
adult MDMs, or by an intrinsically weaker response in neonatal
MDMs. The latter is supported by the observation that there
is an age-related increase of CCR5 expression in monocytes,
lymphocytes, and NK cells [43].
Via chemokine receptor CCR5, chemokines such as CCL3,
CCL4, CCL5, CCL6, and CCL8 exert their biological functions.
Recently, it has been reported that virus-induced CCL5 (but
not CCL3 or CCL4) and activation of CCR5 (but not CCR1
or CCR3) are required to prevent apoptosis of influenza virus–
infected mouse macrophages in vivo and human macrophages
ex vivo [28]. As is shown in our study, significantly higher
expression of CCL5 was detected in avian influenza virus–in-
fected human MDMs than in human influenza virus H1N1/
98–infected MDMs (figures 2, 3, and 4). In human patients
and mouse models, it has been found that the replication of
H5N1 virus or H5N1 nonstructural gene reassortant virus is
prolonged [14, 44]. We have recently demonstrated that lesser
cytopathogenic effects were caused by avian influenza viruses
H9N2/G1 and H5N1/97 in Jurkat T cells [23] and other cell
types, such as dendritic cells (data not shown), compared with
human virus H1N1/98. The lesser cytopathogenic effects or
lower percentages of apoptosis in avian influenza virus–infected
cells may contribute to the prolonged viral replication, and this
process may be a result of the antiapoptotic effects of CCL5
and CCR5.
H9N2/G1 and H5N1/97 share 6 internal genes [17]. The fact
that enhanced chemokine and chemokine-receptor responses
were induced by both avian viruses suggested that these viral
genes or their proteins may be involved in the induction of
responses. More recently, mice infected with the reconstructed
virus bearing hemagglutinin and/or neuraminidase of the 1918
Spanish influenza virus also showed significantly enhanced pro-
duction of tumor necrosis factor–a, CCL3, CXCL2, and IFN-
g, as well as high mortality [45, 46]. Since the amino acid
changes detected in polymerase PA, PB1, and PB2 of the 1918
Spanish influenza virus were also detected in H5N1 and H9N2
viruses [47], further investigation is needed to determine their
roles.
Altogether, our findings suggest that there is similar infec-
tivity and viral replication but different chemokine and che-
mokine-receptor responses of human MDMs to human and
avian influenza viruses. In general, the chemokine and che-
mokine-receptor responses of MDMs to avian influenza virus-
es were much stronger than those to human virus, which may
account for the high pathogenicity of avian viruses. There were
specific differences in responses—for example, greater CCL3,
CCR1, and CCR5 expression—in avian influenza virus H5N1/
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97–infected adult MDMs, compared with those in neonatal
MDMs. These data suggest that host factors may influence the
disease process or outcome.
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